Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 4 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 1

Conditions

Weight Loss 1Multiple Endocrine Neoplasia Type 1 1Cachexia 1

Interventions

Exercise 440Blood Specimen Collection 335Standard of Care 325Magnetic Resonance Spectroscopy 260Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Methods 231Educational Status 231Early Intervention, Educational 219Interviews as Topic 149Practice Guidelines as Topic 147Biopsy 146Surgical Procedures, Operative 136Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 96Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 83Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Atenolol × Clear all
NCT00625742 2016-02-12

Multimodal Treatment Strategy for Cancer Cachexia

M.D. Anderson Cancer Center

Phase NA Terminated
15 enrolled 4 charts

Cachexia, Weight Loss

NCT01795235 2013-02-20

Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones

University of Virginia

Phase NA Unknown
6 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡